[Skip to Content]
[Skip to Content Landing]
Article
January 1992

Somatostatin in the Management of Gastrointestinal FistulasA Multicenter Trial

Author Affiliations

From the Departments of Surgery, The University Hospital of San Carlos (Drs Torres, Argüello, Hernandez-Merlo, and Balibrea), The Red Cross Hospital (Drs Moreno-Azcoita and Jover), The 12th of October Hospital (Drs Landa and Moreno-Gonzales), Madrid, Spain, and the Umberto I Hospital (Dr Silecchia), Rome, Italy.

Arch Surg. 1992;127(1):97-100. doi:10.1001/archsurg.1992.01420010115018
Abstract

• To evaluate the effectiveness of treatment with total parenteral nutrition (TPN) alone (group A) or combined with continuous intravenous infusion of somatostatin (group B) in postoperative gastrointestinal fistulas, a multicenter, controlled and prospective randomized trial was designed. We present the results obtained after the evaluation of 40 cases (group A, n = 20; group B, n = 20). No significant differences among these treatment schedules were observed in the percentage of closure of fistulas (group A, 81.25%; group B, 85%), but patients treated with total parenteral nutrition plus somatostatin had the fistulas close within a significantly shorter period of time. Moreover, this treatment was associated with a significantly lower morbidity. These preliminary results indicate that somatostatin is a useful therapeutic complement in the conservative treatment of patients with gastrointestinal fistulas.

(Arch Surg. 1992;127:97-100)

×